Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.39 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.39 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.39 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12662945 | 0.87 | — | — | |
| SCHEMBL4400999 | 0.87 | — | — | |
| SCHEMBL6940482 | 0.85 | MMP1 (0.46) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL15202789 | 0.85 | MEN1 (0.52) | KMT2AMEN1EPHX1 | |
| SCHEMBL9502637 | 0.85 | — | — | |
| SCHEMBL14205943 | 0.85 | — | — | |
| SCHEMBL16626 | 0.83 | — | — | |
| SCHEMBL7826225 | 0.83 | — | — | |
| SCHEMBL261066 | 0.83 | — | — | |
| SCHEMBL4529642 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4163797-A | CARBAMOYL OR SULFAMOYL STABILIZER | THE DOW CHEMICAL COMPANY (US) | 1979-08-07 | — | — | US | claimed |
| CN-122059906-A | Compounds for inhibiting PTPN proteins and uses thereof | 艾斯拓康生物医药(天津)有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122010871-A | Compounds for inhibiting PTPN proteins and uses thereof | 艾斯拓康生物医药(天津)有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-3792241-B1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO PERFUMERY CO LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20250359576-A1 | THEANINE-CONTAINING COMPOSITION | TAIYO KAGAKU KK (JP) | 2025-11-27 | — | — | US | disclosed |
| CN-119118882-A | Olatinib intermediate and preparation method thereof and preparation method of Olatinib | 浙江荣耀生物科技股份有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-117143492-A | Release agent and preparation method thereof, release film and preparation method of release film | 浙江永盛科技有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20230312457-A1 | LOW-MIGRATION HINDERED PHENOL ANTIOXIDANT COMPOUND, PREPARATION METHOD AND COMPOSITION | TSENG, JERRY (TW) | 2023-10-05 | — | — | US | disclosed |
| US-20230312457-A1 | LOW-MIGRATION HINDERED PHENOL ANTIOXIDANT COMPOUND, PREPARATION METHOD AND COMPOSITION | TSENG, JERRY (TW) | 2023-10-05 | — | — | US | disclosed |
| CN-116157444-A | Poly (amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery | 耶鲁大学 | 2023-05-23 | — | — | CN | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| US-20030148188-A1 | Active materials in the positive electrodes of batteries. Novel methods for preparing the tetraketopiperazine unit-containing compounds include: (i) reacting an oxalyl halide and an oxamide, and adding water or an aqueous alkali | IM&T RESEARCH, INC. | 2003-08-07 | — | — | US | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060019-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| US-20030041936-A1 | Method for producing dinitro-diaza-alkanes and interediate products thereto | NITROCHEMIE ASCHAU GMBH (DE) | 2003-03-06 | — | — | US | disclosed |
| EP-0516006-B1 | 4,4'-Biphenylenediphosphonite compound and use thereof | YOSHITOMI PHARMACEUTICAL (JP) | 1996-10-23 | — | — | EP | disclosed |
| EP-0516006-A1 | 4,4'-Biphenylenediphosphonite compound and use thereof | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1992-12-02 | — | — | EP | disclosed |
| US-4163797-A | CARBAMOYL OR SULFAMOYL STABILIZER | THE DOW CHEMICAL COMPANY (US) | 1979-08-07 | — | — | US | disclosed |
| US-4006140-A | AGING RESISTANCE IMPROVERS FOR VULCANIZABLE RUBBERS | THE B. F. GOODRICH COMPANY (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312457-A1 | LOW-MIGRATION HINDERED PHENOL ANTIOXIDANT COMPOUND, PREPARATION METHOD AND COMPOSITION | COMT, CAT, GPX4 | MMP1 90/4885MMP2 16/4885MMP3 52/4885 |
| US-20030041936-A1 | Method for producing dinitro-diaza-alkanes and interediate products thereto | DAO, DDO, ACMSD | MMP1 1777/4885MMP2 3383/4885MMP3 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.